![Mardi Dier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 53 300 $ in data 30/06/2026
La signora Mardi C. Dier è direttore finanziario e vicepresidente esecutivo di Ultragenyx Pharmaceutical, Inc., direttore indipendente di Oric Pharmaceuticals, Inc. e direttore indipendente di Adamas Pharmaceuticals, Inc. Fa parte del Consiglio di amministrazione di Prelude Therapeutics, Inc., Oric Pharmaceuticals, Inc. e Adamas Pharmaceuticals, Inc. La sig.ra Dier è stata precedentemente impiegata come CFO, Chief Business Officer & Executive VP di Portola Pharmaceuticals, Inc., Vice President-Investor Relations di Chiron Corp., Director-Investment Banking di Prudential Equity Group LLC, Senior Accountant di KPMG LLP, Senior Accountant di KPMG Peat Marwick LLP e Director-Investment Banking di Prudential Securities. È stata anche membro del consiglio di amministrazione del Jewish Vocational Service, Inc. e del Futures Strategic Trust. Si è laureata alla Stanford University e ha conseguito un MBA alla UCLA Anderson School of Management.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/06/2025 | 10.000 ( 0,02% ) | 53 300 $ | 30/06/2026 | |
| 01/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/02/2020 |
| MADRIGAL PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 11/03/2024 |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Consulente / Consigliere | - |
Synthekine, Inc.
 Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Direttore/Membro del Consiglio | 03/06/2021 |
| Società | Posizione | Fine |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Direttore/Membro del Consiglio | 17/10/2025 |
| ACELYRIN, INC. | Direttore Finanziario/CFO | 02/08/2023 |
| ULTRAGENYX PHARMACEUTICAL INC. | Direttore Finanziario/CFO | 15/11/2022 |
| ADAMAS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 09/06/2021 |
| PORTOLA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/07/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 18 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Futures Strategic Trust
 Futures Strategic Trust Investment Banks/BrokersFinance Invests in commodities contracts | Finance |
Prudential Securities
 Prudential Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KPMG Peat Marwick LLP
 KPMG Peat Marwick LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Prudential Equity Group LLC
 Prudential Equity Group LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Finance |
Jewish Vocational Service, Inc.
 Jewish Vocational Service, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization that provides adult education and workforce development services | Commercial Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oric Pharmaceuticals, Inc.
 Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Madrigal Pharmaceuticals, Inc.
 Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Synthekine, Inc.
Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
